Movement Disorders in Childhood


The clinical evaluation of childhood movement disorders depends on the crucial step of phenomenology that precedes and guides evaluation and management. Historically, many of the chronic movement disorders were identified as phenotypic syndromes based on clinical presentation, associated symptoms, and disease course. With the growing availability of genetic testing, more of the underlying metabolic and heredodegenerative disorders causing chronic movement disorders are being identified, producing a clearer understanding of the full clinical spectrum of these disorders ( Fig. 40.1 ).

Fig. 40.1
A systematic approach to diagnosis in patients presenting with movement disorders.

From Abdo WF, van de Warrenburg BPC, Burn DJ, et al. The clinical approach to movement disorders. Nat Rev. 2010;6:29–37 [ Fig. 1 , p. 34].

Movement Disorders

Movement disorders are a group of disorders where there is excessive movement or a paucity of voluntary movement ( Table 40.1 ). The problem is not primarily due to weakness or abnormality of tone (spasticity). This group of disorders is characterized by difficulty initiating movement, abnormal control of voluntary movement, abnormalities of posture, or the presence of unwanted involuntary movements. Primary movement disorders imply a dysfunction in the basal ganglia and its connections or dysfunction of the cerebellum and its connections.

TABLE 40.1
Types of Childhood Movement Disorders
  • Dystonia

  • Chorea, athetosis, ballismus

  • Myoclonus

  • Tremor

  • Ataxia

  • Stereotypies

  • Tics

Movements disorders in general can be divided into two main categories. There may be a paucity of normal voluntary movements ( hypokinetic ) or the presence of abnormal involuntary movements ( hyperkinetic ). The hyperkinetic movement disorders include dystonia, ataxia, tremor, chorea, athetosis, ballismus, tics, and myoclonus. In the hypokinetic disorders there is a paucity or decreased amplitude of normal voluntary movements (hypokinesia), slow voluntary movements or difficulty initiating voluntary movement (bradykinesia), or loss of movement (akinesia). One example of a hypokinetic movement disorder is parkinsonism (resting tremor, slow voluntary movements, rigidity).

Chief Complaint

The presenting symptom or chief complaint in a child with a movement disorder may be any of the following:

  • Inability to sit still

  • Gait abnormality

  • Twitching

  • “Weakness” or dropping things

  • Shaking/trembling of the hands

  • Unsteadiness

  • Abnormal movements

The goal of the history and examination is to confirm the presence of the abnormal movement and correctly characterize it. Phenomenology is the study or observation of the abnormality. The clinical evaluation of movement disorders emphasizes the question “What type of abnormal movement is present?” or “What is the phenomenology?” rather than “Where is the lesion in the neurologic axis?” Phenomenology is determined by clinical examination, observation, and, when necessary, videotape review. Videotape review is especially useful when a paroxysmal movement is not witnessed during the clinic visit. Phenomenology links directly to potential differential diagnosis as well as choice of symptomatic therapy.

History

The clinical history in the child with a suspected movement disorder should include the course of the problem, whether acute or chronic. Specific information on whether the movements are paroxysmal (episodic) should be obtained. If the abnormal movements are paroxysmal, the history should indicate whether the abnormal movements are task specific (e.g., writer’s cramp, which is a task-specific focal dystonia) and whether there are specific triggers that provoke the abnormal movements. Initiation of sudden movement that triggers dystonia is the hallmark of paroxysmal kinesigenic dystonia or dyskinesia ( Table 40.2 ). Anticipation, emotional change, and stress can increase the frequency of tics. Excitement and emotional distress tend to bring out stereotypies. In general, abnormal movements do not awaken a child from sleep. Most movement disorders disappear in deep sleep except for ballismus and severe torsion dystonia. An abnormal movement that awakens a child from sleep should raise the suspicion for seizures.

TABLE 40.2
Classification of Primary and Epilepsy Paroxysmal Dyskinesias
PKD PNKD PED PHD
Inheritance AD AD AD Usually sporadic
Gender M:F 4:1 2:1 2:3 7:3
Age at onset, yr <1–20 <1–20s 2–30 4–20s
Phenomenology of abnormal movements Dystonia with or without chorea/ballism, uni- or bilateral Dystonia with or without choreoathetosis, uni- or bilateral, rarely spasticity Dystonia, sometimes in combination with choreoathetosis, uni- or bilateral Dystonia, chorea, ballism
Triggers Sudden movement, change in direction, acceleration, startle Alcohol, caffeine, emotions, fatigue Prolonged exercise, muscle vibration Sleep
Duration of paroxysms Seconds up to 5 min 2 min–4 hr 5 min–2 hr 30 min up to 50 min
Frequency of paroxysms 1 per month to 100 per day Few per week to few in a lifetime Few per month Few per year to few per night
Genetics
  • 1.

    EKD1: 16p11.2-q12.1 (DYT10) with PRRT2 gene within this region

  • 2.

    EKD2: 16q13-q22.1 (DYT19)

  • 3.

    EKD3: no variant on chromosome 16

  • 1.

    PNKD : 2q35 (DYT8)

  • 2.

    SCL2A1 : chromosome 1 (DYT9)

  • 3.

    KCNMA1 : 10q22

  • 4.

    Locus on 2q31 (DYT20)

  • 1.

    SCL2A1 : 1p35-p31.3 (DYT18)

  • 1.

    CHRNA4 : 20q13.2-q13.3

  • 2.

    CHRNB2 : chromosome 1q21

  • 3.

    Locus on chromosome 15q24

  • 4.

    Locus on chromosome 8p21

Treatment Anticonvulsants (carbamazepine, phenytoin, others) Avoiding triggers, benzodiazepines (clonazepam) Avoiding triggers, ketogenic diet (in GLUT-1 deficiency) Anticonvulsants
AD, autosomal dominant; AR, autosomal recessive; PED, paroxysmal exercise-induced dyskinesia; PHD, paroxysmal hypogenic dyskinesia (a seizure disorder); PKD, paroxysmal kinesigenic dyskinesia; PNKD, paroxysmal nonkinesigenic dyskinesia.

Also known as autosomal dominant nocturnal frontal lobe epilepsy.

The history should clarify the areas of the body affected, severity, and degree of functional impairment. Associated neurologic symptoms such as weakness, visual disturbance, seizures, and mental status changes imply a more widespread neurologic process than that primarily affecting the basal ganglia. Symptoms such as fever, rash, and pharyngitis suggest the presence of systemic illness.

The impact of the abnormal movement on the child’s day-to-day function as well as limitations of function should be documented.

A detailed academic, behavioral, and psychiatric history should be obtained as movement disorders are often accompanied by behavioral, emotional, cognitive, and psychiatric comorbidities.

The history should include medications that have been recently started or stopped as well as chronic medications.

The child’s birth and developmental history clarify whether the movement disorder occurred in a child who had no preceding neurologic conditions or in a child who had prior neurologic/developmental difficulty. The age of onset may provide a clue to the diagnosis ( Fig. 40.2 and Table 40.3 ).

Fig. 40.2, Onset of different paroxysmal movement disorders (PMDs) according to age. BNSM, benign neonatal sleep myoclonus; BMEI, benign myoclonus of early infancy; BPTI, benign paroxysmal torticollis of infancy; PEM, paroxysmal eye movements; PED, paroxysmal exercise-induced dyskinesia; PKD, paroxysmal kinesigenic dyskinesia; PNKD: paroxysmal nonkinesigenic dyskinesia.

TABLE 40.3
IEMs Associated with Movement Disorder by Age at Onset
From Ortigoza-Escobar JD. A proposed diagnostic algorithm for inborn errors of metabolism presenting with movements disorders. Front Neurol . 2020;11:582160, Table 2 .
Prenatal Neonatal Infancy and Childhood Adolescence and Adulthood
  • Atypical Gaucher disease due to saposin C deficiency

  • Glycine encephalopathy

  • Hyperekplexia or hyperexcitability: SUOX—isolated sulfite oxidase deficiency

  • Absence of voluntary movements or HRS: CLPB 3-methylglutaconic aciduria disorder, ADSL adenylosuccinate lyase deficiency, and PC pyruvate carboxylase deficiency

  • Myoclonic jerks: GLDC and ATM-glycine encephalopathy

  • Tremor, jitteriness, dystonia: HTRA2 3-methylglutaconic aciduria type 8

  • Most of the IEMs presenting with MD begin in this age group

  • Onset before 2 yr of age: disorders of purine and creatine metabolism, neurotransmitter disorders, propionic and methylmalonic acidemia, glutaric aciduria type 1, disorders of cobalamin metabolism, biotinidase deficiency, manganese disorders (SLC39A8), GLUT-1 deficiency, mitochondrial disorders (including Leigh syndrome), SNX14 deficiency, CLN14 disease, Niemann-Pick type C, sialidosis, PMM2-CDG and other congenital disorders of glycosylation

  • Adult-onset ataxia:

  • 3-methylglutaconyl-CoA hydratase deficiency, 3-phosphoglycerate dehydrogenase deficiency, g-glutamylcysteine synthetase deficiency, OPA1 deficiency, very long-chain fatty acid elongase 4 deficiency, very long-chain fatty acid elongase 5 deficiency, abetalipoproteinemia, hereditary coproporphyria, complex MD (tremor, ataxia, myoclonus, perioral dyskinesias), cathepsin F deficiency (myoclonus, cerebellar ataxia, parkinsonism), neuronal ceroid lipofuscinosis type 4 (Parry type)

Many IEMs presenting with MD do not have a specific age of onset, and hence this parameter may not be extremely valuable in evaluating a particular case.IEMs, inborn errors of metabolism; MD, movement disorder.

Family history of similar symptoms or a variation of the same type of problem suggests a genetically inherited disorder.

Physical Examination

The general physical examination should determine the presence of systemic signs.

The comprehensive neurologic examination determines whether there are other neurologic abnormalities besides involuntary movements. The mental status examination should include observations about alertness, attention, behavior, mood, and emotions. Cranial nerve examination should specifically determine whether there is nystagmus, limitation of eye movements, or weakness of the face, tongue, and jaw muscles. In general, the motor exam portion of the neurologic examination tends to emphasize muscle tone, strength, and the muscle stretch reflexes (deep tendon reflexes). This portion of the motor exam is effective in identifying the presence of weakness, spasticity, or hypotonia. Some features of involuntary movements such as the inability to maintain a voluntary contraction may be detected during the general motor examination. The template of the motor examination that starts with muscle tone, then goes on to testing of strength, and ends with reflex testing is useful for localization but insufficient for characterization of abnormal movements. Although it is assumed that general observation of the patient occurs throughout the visit, this alone is often insufficient for accurate characterization of the movement disorder. Therefore, once the motor exam that assesses tone, strength, and reflexes is completed, an additional portion of time should be allocated specifically for the observation of the involuntary movements to categorize them (phenomenology).

Posture and abnormal movements should be observed while the patient is in the recumbent position, in the seated position, standing upright with arms by the side, and then standing with arms and fingers outstretched. The child’s ability to maintain a voluntary posture or voluntary muscle contraction should be assessed. This includes the ability to maintain grip while holding the examiner’s hands and the ability to maintain tongue protrusion. Observation of tasks such as picking up, grasping, playing with small toys, pouring water from glass to glass, and writing is useful in the characterization of involuntary movements affecting the upper extremities, trunk, and neck. Stance, gait, swivel, running, stooping, and recovering should be assessed. Observation of speech is important as abnormal movements of the tongue, palate, lower face, and jaw affect the quality of speech. Abnormal movements of the laryngeal muscles affect voice production and quality. Motor impersistence and parakinesia (described in the section on chorea) should be recognized and identified when present. Paroxysmal movements such as tics may be briefly suppressible during a voluntary motor task, only to emerge once the task is accomplished. Tics when mild may not be witnessed in the clinic. Paroxysmal kinesigenic dystonia is often provoked by getting up from the seated position or at the beginning of a short sprint (see Table 40.2 ). Paroxysmal movements that occur between periods of normalcy may not be witnessed during the examination. When a paroxysmal movement is not witnessed in the clinic, videotape review is often helpful.

The gait examination is an essential component of the neurologic examination in a child with a movement disorder. The various gait abnormalities linked to the different movement disorders are listed in Table 40.4 .

TABLE 40.4
Gait Abnormalities in Movement Disorders
Ataxia Wide-based stance. Extra steps to the side or backward to maintain balance while standing still. Extra steps to the side and a “drunken”-type gait with trunk sway when walking. Veering to the side and falls especially when turning or changing direction. Hurls self forward while running with a tendency to fall at the end of the run. In general, the mildly ataxic child tends to have a harder time standing still or walking slowly compared to running. When severe, standing, walking, and running are all significantly impaired.
Choreoathetosis Lurching-type gait. Difficulty standing still or motionless with intermittent, random jerky movements of arms, neck, trunk, legs, and face giving rise to a “fidgety” appearance.
Tics Normal gait and coordination.
Stereotypies Normal gait.
Dystonia If dystonia is focal and does not involve the legs or trunk, gait may be normal. In generalized dystonia, look for twisting and/or prominent lordosis of the trunk or twisting inward or medially of the legs. The feet may be inverted and plantarflexed. The abnormality tends to become more noticeable the longer the patient walks or runs. When dystonia is severe, the affected limbs tend to move “en bloc” with little apparent flexibility at the joints.
Tremor Gait can be normal. In the parkinsonian patient there is difficulty initiating movement and the gait is often slow and “stiff.” In the patient with orthostatic tremor, standing brings out the tremor in the legs. The tremor disappears or improves when seated or walking.
Myoclonus Gait is usually normal. If myoclonus affects the trunk or legs, lightning-like jerks depending on the amplitude can result in falls.

Dystonia

Dystonia is defined as a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation.

Dystonia can affect any part of the body. Terms used to describe the distribution of dystonia include focal, segmental, multifocal, and generalized. Focal dystonia affects a single body part. Examples of focal dystonia include blepharospasm (involuntary spasms of the eyelids), torticollis (dystonia of the neck muscles), and writer’s cramp (dystonia of the hand). Dystonia that affects two contiguous body parts is referred to as segmental dystonia (e.g., neck and arm or face and arm). Dystonia of two noncontiguous body parts is referred to as multifocal dystonia. Dystonia on one side of the body (e.g., left leg and left arm) is described as hemidystonia. Dystonia of more than one limb with involvement of the trunk is termed generalized dystonia. Dystonia may affect the larynx in isolation as a focal dystonia or as part of a more generalized dystonia giving rise to a “strangled,” “whispery,” or “breathy” quality of voice production. The distribution of dystonia may be sometimes helpful in localization. For example, acute hemidystonia may be due to pathology in the contralateral basal ganglia. The documentation of the distribution of dystonia also helps in the clinical detection of progression of disease over time.

The clinical evaluation of a patient with dystonia should delineate the time course of symptoms (acute, subacute, or chronic), distribution, whether it is present all the time or paroxysmal (if paroxysmal, whether it is provoked by initiation of movement), whether there is a diurnal variation (worse toward the end of the day), presence of other symptoms, and family history of similar conditions.

The etiology or underlying causes of pediatric dystonia are quite heterogenous. It is helpful in the clinical setting to differentiate acute dystonia from subacute or chronic dystonia. Acute dystonia in general suggests that the dysfunction in the brain is acute and therefore should be evaluated urgently. Associated symptoms of fever or systemic symptoms suggest a primary central nervous system (CNS) infection or inflammation that requires urgent evaluation.

Subacute and chronic dystonia are usually due to more slowly progressive acquired conditions, genetic disorders, or heredodegenerative conditions.

Acute Dystonia

When faced with a child presenting with acute dystonia, the evaluation should be conducted rapidly considering drugs/toxins, infection, inflammation, and acute ischemia as possible causes ( Table 40.5 ).

TABLE 40.5
Differential Diagnosis of Acute Dystonia
  • Drugs: L-dopa, dopamine antagonists, fenfluramine, antipsychotics, antiemetics, anticonvulsants, flecainide, ergots, some calcium channel blocking agents

  • Toxins: carbon monoxide, magnesium, carbon disulfide, cyanide, methanol, disulfiram, wasp sting

  • Structural: stroke or lesion involving the basal ganglia

  • Infection: viral or bacterial encephalitis; other infections with focal brain lesions: tuberculosis, neurocysticercosis

  • Inflammation: involving the basal ganglia: acute disseminated encephalomyelitis (ADEM), N -methyl- d -aspartate receptor (NMDAR) encephalitis, rarely antiphospholipid antibody syndrome

In these situations, dystonia is often not isolated and is often accompanied by systemic symptoms and signs or other abnormalities in the neurologic system such as mental status changes, seizures, or acute psychiatric symptoms.

Infections

Viral or bacterial encephalitis may affect the basal ganglia, giving rise to an acute movement disorder with dystonia, usually in the setting of systemic symptoms and symptoms arising from multifocal involvement of the brain.

Inflammation

Postinfectious syndromes such as acute disseminated encephalomyelitis (ADEM) may present with a mixed movement disorder with dystonia.

N -methyl- d -aspartate receptor (NMDAR antibody) encephalitis is one of the more well-defined autoimmune disorders presenting with both movement disorders (chorea, dystonia) and neuropsychiatric symptoms. The symptoms usually evolve in a subacute to chronic fashion occasionally with acute worsening. A clinical suspicion of the condition, often with MRI signal changes in the hippocampi, mesial temporal lobes, thalamus, and brainstem (not all cases have MRI changes), with NMDAR antibody positivity in serum and cerebrospinal fluid (CSF) help clinch the diagnosis. Screening for an underlying tumor should be undertaken. Cases in children and adolescents have been linked to ovarian or testicular teratoma, seminoma, and small-cell lung cancer. The incidence of tumors in children with this condition is lower than that of adults. Management is with immune therapy following tumor resection (in the cases linked to tumors).

Acute Dystonic Reactions from Medications

Areas affected include the jaw muscles (trismus), neck (torticollis), back (opisthotonus), and extraocular muscles (oculogyric deviation of eyes). The patient may also have trouble chewing or swallowing. Although these sudden movements can mimic seizures, the patient remains fully aware of their surroundings and the dystonia resolves almost immediately with intravenous Benadryl. Commonly used medications such as antiemetics, anticonvulsants, and neuroleptics with dopamine-blocking properties can give rise to acute or delayed dystonic reactions.

Paroxysmal Dystonia

Paroxysmal dystonia in sleep should raise the suspicion of seizures and appropriate neurophysiologic evaluation may be needed to differentiate seizures from a movement disorder. Paroxysmal dystonic movements with alteration of consciousness should also raise the suspicion of seizures ( Table 40.6 ).

TABLE 40.6
Differential Diagnosis of Paroxysmal Dystonia
  • Paroxysmal kinesigenic dystonia

  • Paroxysmal nonkinesigenic dystonia

  • Sandifer syndrome

  • Benign paroxysmal dystonia

  • Seizures

  • Alternating hemiplegia of childhood

Paroxysmal Kinesigenic Dyskinesia

Paroxysmal dystonia or choreoathetosis triggered by the initiation of movement suggests the diagnosis of paroxysmal kinesigenic dyskinesia (PKD) (see Table 40.2 ). PKD appears to be a heterogenous disorder in which initiation of movement triggers episodes of dystonia or choreoathetoid movements. The symptoms are often unilateral. Onset of symptoms is between ages 1 and 20 years. The episodes of dystonia are clinically distinct from seizures because consciousness is fully preserved, and the episodes are triggered by the initiation of movement. There is no associated pain with these episodes. The episodes last seconds to less than a minute. Some patients have additional neurologic disorders such as benign infantile epilepsy. Infantile convulsions followed by PKD in late childhood or adolescence is thought to be a variant form of PKD.

The diagnosis of PKD is confirmed by the absence of organic disease or structural abnormality on neuroimaging and the response to anticonvulsant medications such as carbamazepine, usually in low doses. This condition may be sporadic or familial. Familial PKD can be caused by variants in the proline-rich transmembrane protein 2 ( PRRT2 ). However, this gene is found in only a portion of individuals with PKD. Variants in KCNA1 are identified in some families with PKD. A diagnostic approach to paroxysmal dyskinesias is noted in Fig. 40.3 .

Fig. 40.3, Main genetic causes of recurring paroxysmal episodes of dyskinesia.

Sandifer Syndrome

Episodic arching or dystonic posture of the neck and back in an infant or child can be seen in the setting of reflux. These episodes are usually related to feeds.

Benign Paroxysmal Torticollis

This is thought to be a migraine variant. In this condition children have paroxysmal episodes of head and/or trunk tilt that can last for hours or days, usually without other symptoms. Onset can be as early as the first year of life. Usually these episodes gradually decrease with age and resolve or evolve into episodes of migraine as the child grows older. At initial presentation, a detailed clinical evaluation should be undertaken, with appropriate testing to rule out organic causes. Careful monitoring should occur to determine whether these symptoms evolve into those of migraine or change to suggest a chronic neurogenetic dystonia that would warrant further evaluation.

Alternating Hemiplegia of Childhood

Alternating hemiplegia of childhood (AHC) is a rare condition presenting in childhood with episodes of temporary paralysis, often affecting one side of the body (hemiplegia). The episodes usually occur before age 18 months and last from minutes to days. Although not primarily a movement disorder, individuals can also have episodic choreoathetosis or dystonia in addition to episodes of hemiplegia. The episodes of abnormal movements can occur during or separate from the episodes of paralysis. These episodes can occur with triggers of stress, cold, or extreme tiredness. Sometimes there is no recognizable trigger. Other potential symptoms include developmental delay, abnormal eye movements, and seizures. Most individuals have pathogenic variants in ATP1A3, and a smaller number have variants in ATP1A2 . There is a high rate of de novo (sporadic) events, so many patients do not have a family history of similar symptoms. When there is a family history, it tends to follow an autosomal dominant pattern. Several treatments have been used including flunarizine, benzodiazepines, topiramate, oral adenosine triphosphate (ATP), coenzyme Q, acetazolamide, aripiprazole, and dextromethorphan, with various rates of success in aborting attacks or decreasing their frequency.

Chronic Dystonia

Classification of chronic dystonia is linked to etiology ( Tables 40.7 and 40.8 ).

  • Primary pure dystonia: Dystonia is the only clinical symptom and there is no identifiable exogenous cause or other inherited degenerative disease.

  • Primary dystonia plus syndromes: Dystonia may be a prominent or early sign but there are other abnormal movements such as myoclonus, ataxia, or parkinsonism, and there is no evidence of neurodegeneration.

  • Primary paroxysmal dystonia: Dystonia occurs in brief episodes with normalcy in between. These disorders can be familial or sporadic.

  • Secondary dystonia: Dystonia is a symptom of an identified neurologic condition such as brain tumor, stroke, infection, inflammation, drugs, or toxins.

  • Heredodegenerative: Dystonia is one of many other neurologic signs or symptoms of a heredodegenerative or metabolic disorder (see Table 40.8 ).

TABLE 40.7
Types of Chronic Dystonia
Primary (Pure) Dystonia
Autosomal Dominant

  • Idiopathic torsion dystonia: DYTI (TOR1A)

  • Idiopathic torsion dystonia/whispering dysphonia: DYT4 (TUBB4A)

  • Adolescent/early adulthood onset: DYT6 (THAP1)

  • DYT13

Autosomal Recessive

  • DYT17

Primary Dystonia Plus Syndromes
Autosomal Dominant

  • Guanosine triphosphate (GTP) cyclohydrolase-1: DYT5 (dopa-responsive dystonia)

  • Dystonia myoclonus: DYT11: epsilon sarcoglycan gene variant

  • Rapid-onset dystonia parkinsonism: DYT12

  • Alcohol-responsive dystonia myoclonic dystonia: DYT15

Autosomal Recessive

  • Young-onset dystonia parkinsonism: DYT16

Primary Paroxysmal Dystonia

  • Paroxysmal kinesigenic dyskinesia (PKD): DYT10 (PxMD-PRRT2)

  • Paroxysmal nonkinesigenic dyskinesia (PNKD1): DYT8 (PxMD-PNKD)

  • Paroxysmal exercise-induced dyskinesia (PED): DYT18 (PxMD-SLC2A1) gene variants

Secondary Dystonia

  • Structural defects: stroke, tumor

  • Infection/inflammation

  • Drugs, toxins

  • Hypoxic-ischemic encephalopathy

  • Rasmussen syndrome

DYT, prefix nomenclature for numbering monogenic dystonias.

TABLE 40.8
Diseases with Complex Symptoms and Dystonia: Inherited Neurodegenerative/Metabolic Disorders
Klein C, Lohmann K, Marras C, et al. Hereditary dystonia overview. In: GeneReviews [Internet]. Seattle: University of Washington, 1993–2021. 2003 Oct 28 [updated 2017 Jun 22], Table 4 .
Disorder MOI Gene(s) Clues to the Diagnosis
Neurodegenerative Diseases
DRPLA (dentatorubral-pallidoluysian atrophy) AD ATN1 Huntington disease–like; prominent myoclonus
Huntington disease (Westphal variant juvenile- or childhood-onset HD) AD HTT Family history; caudate atrophy on MRI
Huntington disease–like 2 AD JPH3 African ancestry
Rett or Rett-like syndrome XL, AD MECP2, FOXG1, GNB1 Unusual stereotypies; autism
Parkin type of early-onset Parkinson disease AR PARK2 Abnormal DaTscan
Chorea-acanthocytosis AR (and possible AD) VPS13A Acanthocytes in blood smear
McLeod neuroacanthocytosis syndrome XL XK Weak expression of Kell antigens; acanthocytes in blood smear
Neuronal intranuclear inclusion disease AD or sporadic Unknown MRI: high-intensity signal in cortico-medullary junction on DWI images; intranuclear inclusions on skin biopsies
Disorders Leading to Brain Calcification
Primary familial brain calcification AD PDGFB , PDGFRB , SLC20A2, XPR1 MRI/CT: calcifications in basal ganglia, white matter, and cerebellum
Disorders of Heavy Metal Metabolism
Wilson disease AR ATP7B ↓ Plasma ceruloplasmin; Kaiser-Fleischer corneal ring; face of the giant panda sign on MRI
Hypermanganesemia with dystonia, polycythemia, and cirrhosis AR SLC30A10 T1-weighted hyperintensities in basal ganglia and cerebellum on MRI
AR SLC39A14
Neurodegeneration with Brain Iron Accumulation (NBIA)
Mitochondrial membrane protein-associated neurodegeneration AR C19orf12 T2-weighted hypointensities in substantia nigra and globus pallidus on MRI; T2-weighted hyperintense streaking between hypointense internal globus pallidus and external globus pallidus
Aceruloplasminemia AR CP MRI: hypointensity of basal ganglia, thalamus, red nucleus, occipital cortex, and cerebellar dentate nuclei on T2-weighted images
Woodhouse-Sakati syndrome AR DCAF17 Dystonia deafness syndrome; hypogonadism; alopecia
Fatty acid hydroxylase–associated neurodegeneration AR FA2H MRI: hypointensity of the globus pallidus, confluent hyperintensities of white matter on T2-weighted images, pontocerebellar atrophy, thin corpus callosum
Neuroferritinopathy AD FTL MRI: cystic lesions in the basal ganglia, bilateral pallidal necrosis; hypointensity of caudate, globus pallidus, putamen, substantia nigra, and red nuclei on T2-weighted images
Pantothenate kinase–associated neurodegeneration AR PANK2 Eye-of-the-tiger sign on MRI
PLA2G6 -associated neurodegeneration AR PLA2G6 Cerebellar hypoplasia and T2-weighted high signal in the cerebellum on MRI
β-Propeller protein–associated neurodegeneration XL WDR45 MRI: hypointense globus pallidus and substantia nigra on T2-weighted images
Lipid Storage Disorders
Neuronal ceroid-lipofuscinoses AR; adult-onset AD or AR ATP13A2 , CLN3 , CLN5 , CLN6 , CLN8 , CTSD , CTSF , DNAJC5 , GRN , KCTD7, MFSD8 , PPT1 , TPP1 Dementia; epilepsy; visual loss in children
Fucosidosis AR FUCA1 MRI: hypointensity of globus pallidus and substantia nigra on T2-weighted images; dysostosis multiplex
Niemann-Pick disease type C AR NPC1 , NPC2 Supranuclear gaze palsy, splenomegaly, ↑ oxysterol blood levels
Sphingolipidosis
Arylsulfatase A deficiency AR ARSA Progressive demyelination
Lysosomal Storage Diseases
Krabbe disease AR GALC Progressive demyelination, enlargement of optic nerve and chiasm
GM1-gangliosidosis AR GLB1 MRI: hyperintensity of caudate nucleus and putamen with signs of diffuse hypomyelination on T2-weighted images
GM2-gangliosidosis, AB variant AR GM2A Indistinguishable from GM1-gangliosidosis
Leukodystrophies
Creatine deficiency syndromes GAMT , GATM, SLC6A8 MR spectroscopy: no creatine peak
Pelizaeus-Merzbacher disease XL PLP1 Hypomyelination on MRI
Disorders of Purine Metabolism
Lesch-Nyhan syndrome XL HPRT1 Self-mutilation; ↑ uric acid in plasma and urine
Mitochondrial Disorders
Leigh syndrome AR, mt Pathogenic variants in the mtDNA; nuclear genes Bilateral basal ganglia lesions on MRI; ↑ lactate levels on magnetic resonance spectroscopy
Leber hereditary optic neuropathy Mt Pathogenic variants in the mtDNA Optic nerve changes on fundoscopy
MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) Mt Pathogenic variants in the mtDNA Deep white matter changes and strokelike lesions on MRI
MERRF (myoclonus epilepsy associated with ragged-red fibers) Mt Pathogenic variants in the mtDNA Progressive myoclonus, epilepsy, and ataxia; muscle biopsy showing ragged-red fibers; ↑ lactate in serum and CSF
POLG -related disorders AR, AD POLG Progressive external ophthalmoplegia, ataxia
Deafness-dystonia-optic neuronopathy syndrome (Mohr-Tranebjaerg syndrome) XL TIMM8A Dystonia (particularly oromandibular) and deafness
Other dystonia-deafness syndromes AD SERAC1, SUCLA2 Dystonia and deafness
XL DDP Dystonia and deafness
Organic Acidurias
D-2-hydroxyglutaric aciduria AR D2HGDH Newborn screening
Glutaric aciduria type 1 AR GCDH Newborn screening
Methylmalonic acidemia AR MCEE , MMAA , MMAB , MMADHC, MMUT Newborn screening
Aminoacidurias
Homocystinuria caused by cystathionine β-synthase deficiency AR CBS Homocysteine levels ↑ in blood
Phenylketonuria AR PAH Newborn screening
Hartnup disorder AR SLC6A19 Levels of neutral amino acids ↑ in urine
Disorders of Biotin Metabolism
Biotinidase deficiency AR BTD Newborn screening
Disorders of Thiamine Metabolism
Biotin-thiamine-responsive basal ganglia disease AR SLC19A3 Recurrent subacute encephalopathy; symmetric and bilateral edematous lesions in caudate nucleus, putamen, and cortex on MRI
Disorders of Galactose Metabolism
Classic galactosemia and clinical variant galactosemia AR GALT Newborn screening
Encephalopathy with Uncertain Pathogenesis
Aicardi-Goutières syndrome AD, AR ADAR , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , TREX1 Early-onset encephalopathy; chilblain lesions
Disorders with ataxia as a predominant feature, particularly AD SCA (e.g., SCA3) and AR early-onset ataxias (e.g., ataxia-telangiectasia)
AD, autosomal dominant; AR, autosomal recessive; CSF, cerebrospinal fluid; DWI, diffusion-weighted imaging; MOI, mode of inheritance; mt, mitochondrial; SCA, spinocerebellar ataxia; XL, X-linked.

Genes associated with mitochondrial DNA-associated Leigh syndrome and NARP: BCS1L, C20ORF7, C8ORF38, COX10, COX15, FOXRED1, MTFMT, NDUFA2, NDUFA9, NDUFA10, NDUFA12, NDUFAF2, NDUFAF6, NDUFS1, NDUFS3, NDUFS4, NDUFS7, NDUFS8, SDHA, SURF1 .

Primary Dystonia

Early-Onset Dystonia

Early-onset idiopathic torsion dystonia caused by variants in DYTI ( TOR1A /torsin A) represents the most common and most severe form of pure primary chronic dystonia in childhood. Previously referred to as dystonia musculorum deformans, it accounts for 16–53% of pediatric-onset dystonia in the non-Jewish population and for 80–90% of cases in the Ashkenazi Jewish population. The dystonia usually begins in childhood or early adolescence as a focal dystonia either in the hand or foot and gradually progresses. Rarely the neck or facial muscles may be involved first. Treatment is symptomatic.

Dopa-Responsive Dystonia

This group of disorders with onset in childhood, adolescence, or early adulthood presents with dystonia with dramatic and sustained response to levodopa. This condition was initially referred to as dopa-responsive dystonia (DRD) with marked diurnal fluctuation or Segawa syndrome. Symptoms have marked diurnal fluctuation, with mild or minimal dystonia in the morning (after overnight sleep), progressively worsening toward the end of the day. Several clinically similar conditions with dystonia have been described, all with the common features of diurnal variation and responsiveness to levodopa. The collective group of DRD appears to be a fairly heterogenous group with either a dominant or recessive pattern of inheritance. Although most cases of DRD in childhood are due to pathogenic variants in guanosine triphosphate (GTP) cyclohydrolase 1 (GCH1) , other abnormalities such as compound heterozygous variants in GCH1, tyrosine hydroxylase (TH) , sepiapterin reductase (SPR) , or 6-pyruvoyltetrahydropterin synthase (6-PTS) genes have been found. Older adolescents with symptoms of DRD have been linked to juvenile parkinsonism and Parkin gene variants. Not all clinical forms have an identified genotype. CSF neurotransmitter metabolites show abnormalities in the dopamine metabolites neopterin and biopterin.

The age of onset is around 6 years, often with dystonia of the foot as the first presenting symptom. This gradually progresses to generalized dystonia. However, onset can be as young as infancy with dystonia and rigidity. It is not uncommon for such young children to be misdiagnosed as having cerebral palsy. Treatment with levodopa results in a dramatic improvement. In a child with chronic dystonia without an identified etiology, a trial of levodopa should be considered.

Symptomatic Dystonia

Acute or subacute hemidystonia should alert the clinician of the possibility of a space-occupying lesion in the contralateral basal ganglia such as a tumor or a stroke.

Hemidystonia has been reported as a symptom of Rasmussen syndrome.

Dystonia has also been reported as an early symptom of ataxia-telangiectasia occurring prior to the onset of ataxia.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here